Development of cytological analysis of pancreatic cancer using homology technology

Development of cytological analysis of pancreatic cancer using homology technology - Development of cytological analysis of pancreatic cancer using homology technology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044462

Enrollment

180

Registered

2021-06-10

Start date

2021-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who underwent EUS-FNA and underwent cytology 2) Patients whose background can be confirmed in medical records

Exclusion criteria

Exclusion criteria: Cases that the principal investigator / coordinator deems inappropriate for inclusion in the study

Design outcomes

Primary

Measure	Time frame
The sensitivity, specificity, and correct diagnosis rate of the homology profile method are calculated by comparing the analysis results of each sample by the homology profile method with the final pathological diagnosis.	—

Countries

Japan

Contacts

Public ContactReiko Yamada

Mie University Hospital Gastroenterology and Hepatology

reiko-t@med.mie-u.ac.jp059(232)1111

Outcome results